Oberoi Sukhvinder Singh, Oberoi Avneet
Department of Public Health Dentistry, Sudha College of Dental Sciences and Research, Faridabad, Haryana, India.
Department of Public Health Dentistry, Oberoi Dental Clinic and Orthodontic Centre, Tagore Garden, New Delhi, India.
Int J Pharm Investig. 2014 Jul;4(3):109-11. doi: 10.4103/2230-973X.138338.
Although the government pays for approximately 20% of drugs used in India, private out-of-pocket expenditure in India on health-care is one of the highest in the world. Preparing pharmacoeconomics guidelines will be an important step in order to establish Health Technology Assessment (HTA) in India. Areas in which HTA could be applied in the Indian context include, drug pricing, development of clinical practice guidelines and prioritizing interventions that represent the greatest value within a limited budget. All this calls for action, both by government and civil-society organizations, to make access to essential medicines a priority.
尽管印度政府支付了约20%的药品费用,但印度民众在医疗保健方面的自付费用却是世界上最高的之一。制定药物经济学指南将是在印度建立卫生技术评估(HTA)的重要一步。在印度背景下,HTA可应用的领域包括药品定价、临床实践指南的制定以及在有限预算内对最具价值的干预措施进行优先排序。所有这些都需要政府和民间社会组织采取行动,将基本药物的可及性作为优先事项。